logo

For the Inventor, By the Inventor

New Haven, CT, United States of America

Biohaven Therapeutics Ltd.


USPTO Granted Patents = 29



Trademarks = 40

Forward Citations = 45

Loading Chart...
Loading Chart...

48 inventors (with patents filed for the assignee):

goldMedal Allen B Reitz (12 out of 101 patents)

silverMedal Jay Edward Wrobel (11 out of 96 patents)

bronzeMedal Garry Robert Smith (11 out of 33 patents)

4.  Haiyan Bian (10 out of 35 patents)

5.  Jeffery Claude Pelletier (8 out of 11 patents)

6.  Vladimir Coric (8 out of 16 patents)

7.  Robert Berman (6 out of 6 patents)

8.  Lynn Resnick (4 out of 13 patents)

9.  George T Topalov (4 out of 31 patents)

10.  Justin K Belardi (4 out of 12 patents)

11.  Charles A Flentge (4 out of 13 patents)

12.  David A Mareska (4 out of 24 patents)

13.  James S Hale (4 out of 13 patents)

14.  Scott S Harried (4 out of 30 patents)

15.  Michael E Bozik (3 out of 26 patents)


29 patents:

1. 12491246 - Combination therapy of arms and natural killer cells (2025-12-09),
2. 12472165 - Riluzole prodrugs and their use (2025-11-18),
3. 12383619 - Use of glutamate modulating agents with immunotherapies to treat cancer (2025-08-12),
4. 12370176 - Methods of use for KV7 channel activators (2025-07-29),
5. 12364687 - Use of riluzole oral disintegrating tablets for treating diseases (2025-07-22),
6. 12351559 - Benzoimidazol benzomidazol-1,2-yl amides as Kv7 channel activators (2025-07-08),
7. 12343347 - Pro-drugs of riluzole and their method of use for the treatment of amyotrophic lateral sclerosis (2025-07-01),
8. 12297206 - Method for synthesizing furoimidazopyridine compound, polymorphic substance and polymorphic substance of salt (2025-05-13),
9. 12295942 - Riluzole prodrugs and their use (2025-05-13),
10. 12286408 - KV7 channel activators compositions and methods of use (2025-04-29),
11. 12213965 - Riluzole prodrugs and their use (2025-02-04),
12. 12201618 - Use of riluzole prodrugs to treat Alzheimer's disease (2025-01-21),
13. 12161633 - Use of riluzole prodrugs to treat alzheimer's disease (2024-12-10),
14. 12121609 - Sublingual formulation of riluzole (2024-10-22),
15. 12102618 - Use of riluzole prodrugs to treat ataxias (2024-10-01),
Biohaven Therapeutics Ltd. is a biopharmaceutical company focused on the development and commercialization of innovative therapies for neurological diseases. The company's pipeline includes treatments for conditions such as migraine, ALS, and Alzheimer's disease.
This text is generated by artificial intelligence and may not be accurate.

logo

Company Badge

USPTO Data Jan 1 1976 - Dec 9 2025

29 Patents

#10 in New Haven, CT

#263 in Connecticut

#11,219 in US

#21,844 in the World

...
New Haven, CT, United States of America

Biohaven Therapeutics Ltd.

Forward Citations = 45

48 inventors:

goldMedal Allen B Reitz (12 out of 101 patents)

silverMedal Jay Edward Wrobel (11 out of 96 patents)

bronzeMedal Garry Robert Smith (11 out of 33 patents)

4.  Haiyan Bian (10 out of 35 patents)

5.  Jeffery Claude Pelletier (8 out of 11 patents)

Please report any incorrect information to support@idiyas.com
Loading…